Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.23.1
Significant Accounting Policies (Tables)
3 Months Ended
Apr. 30, 2023
Accounting Policies [Abstract]  
Summary of Cash, Cash Equivalents, and Restricted Cash

The following table provides a summary of (i) cash and cash equivalents and (ii) restricted cash in the condensed consolidated statements of cash flows as of the periods presented:

 

 

As of April 30,

 

 

 

2023

 

 

2022

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

13,790

 

 

$

16,465

 

Restricted cash

 

 

322

 

 

 

305

 

Total cash, cash equivalents and restricted cash

 

$

14,112

 

 

$

16,770

 

 

 

 

As of January 31,

 

 

 

2023

 

 

2022

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

13,415

 

 

$

17,528

 

Restricted cash

 

 

311

 

 

 

328

 

Total cash, cash equivalents and restricted cash

 

$

13,726

 

 

$

17,856

 

Schedule of Anti-dilutive Securities Excluded from Computation of Net Loss Per Share

The number of common shares used in the computation of diluted net loss per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been antidilutive:

 

 

For the Three Months Ended April 30,

 

 

 

2023

 

 

2022

 

 

 

(Amounts in thousands)

 

Stock options

 

 

33

 

 

 

61

 

RSUs and DSUs

 

 

98

 

 

 

61

 

PSUs

 

 

42

 

 

 

15

 

 

 

 

173

 

 

 

137